Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,083Revenue (TTM) $M906Net Margin (%)-6.5Altman Z-Score3.3
Enterprise Value $M2,333EPS (TTM) $-1.2Operating Margin %-5.5Piotroski F-Score4
P/E(ttm)--Beneish M-Score-3.2Pre-tax Margin (%)-6.5Higher ROA y-yN
Price/Book2.810-y EBITDA Growth Rate %-2.8Quick Ratio1.6Cash flow > EarningsY
Price/Sales2.35-y EBITDA Growth Rate %-16.8Current Ratio2.6Lower Leverage y-yY
Price/Free Cash Flow33.7y-y EBITDA Growth Rate %-71.8ROA % (ttm)-4.4Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-8.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M51.7ROIC % (ttm)-4.8Gross Margin Increase y-yN

Gurus Latest Trades with HAE

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
HAEJoel Greenblatt 2016-09-30 Sold Out -0.01%$29.22 - $37.8
($34.33)
$ 39.7116%Sold Out0
HAEKen Fisher 2016-09-30 Add$29.22 - $37.8
($34.33)
$ 39.7116%Add 3.98%267,712
HAEJoel Greenblatt 2016-06-30 Buy 0.01%$26.13 - $35.32
($30.3)
$ 39.7131%New holding39,575
HAEKen Fisher 2016-06-30 Add$26.13 - $35.32
($30.3)
$ 39.7131%Add 17.50%257,467
HAEBarrow, Hanley, Mewhinney & Strauss 2016-03-31 Sold Out -0.09%$29.84 - $34.98
($32.25)
$ 39.7123%Sold Out0
HAEKen Fisher 2016-03-31 Add$29.84 - $34.98
($32.25)
$ 39.7123%Add 0.01%219,127
HAEBarrow, Hanley, Mewhinney & Strauss 2015-12-31 Reduce-0.02%$30.85 - $34.37
($32.41)
$ 39.7123%Reduce -17.64%1,844,774
HAEKen Fisher 2015-12-31 Add$30.85 - $34.37
($32.43)
$ 39.7122%Add 4.88%219,110
HAEBarrow, Hanley, Mewhinney & Strauss 2015-09-30 Reduce-0.01%$32.32 - $41.05
($37.68)
$ 39.715%Reduce -4.12%2,239,841
HAEJoel Greenblatt 2015-09-30 Sold Out -0.01%$32.32 - $41.05
($37.68)
$ 39.715%Sold Out0
HAEKen Fisher 2015-09-30 Add$32.32 - $41.05
($37.68)
$ 39.715%Add 10.24%208,920
HAEJoel Greenblatt 2015-06-30 Add0.01%$40.11 - $44.93
($42.2)
$ 39.71-6%Add 369.65%35,271
HAEBarrow, Hanley, Mewhinney & Strauss 2015-06-30 Reduce$40.11 - $44.93
($42.2)
$ 39.71-6%Reduce -0.42%2,336,063
HAEKen Fisher 2015-06-30 Reduce$40.11 - $44.93
($42.2)
$ 39.71-6%Reduce -2.43%189,520
HAEJoel Greenblatt 2015-03-31 Buy $36.92 - $45.38
($41.8)
$ 39.71-5%New holding7,510
HAEBarrow, Hanley, Mewhinney & Strauss 2015-03-31 Reduce$36.92 - $45.38
($41.8)
$ 39.71-5%Reduce -0.12%2,345,971
HAEJoel Greenblatt 2014-12-31 Sold Out -0.01%$34.15 - $38.88
($36.69)
$ 39.718%Sold Out0
HAEJoel Greenblatt 2014-09-30 Reduce$34.1 - $37.1
($35.69)
$ 39.7111%Reduce -23.47%29,531
HAERobert Olstein 2014-06-30 Sold Out -0.06%$30.36 - $35.62
($33.37)
$ 39.7119%Sold Out0
HAEFirst Eagle Investment 2014-06-30 Sold Out -0.0009%$30.36 - $35.62
($33.41)
$ 39.7119%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

HAE is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


HAE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MERRIMAN RONALDDirector 2016-08-17Sell4,337$35.1413.01view
FOOTE SUSAN BARTLETTDirector 2016-08-05Sell14,685$35.3512.33view
Simon, ChristopherPresident & CEO 2016-08-04Buy60,000$3513.46view
Selman ByronPresident, Global Markets 2015-10-26Sell344$32.1323.59view
White JonathanChief Science and Technology 2015-10-26Sell319$32.1323.59view
Jesse SandraEVP and Chief Legal Officer 2015-10-26Sell778$32.1323.59view
HANLON SUSAN MVP Finance 2015-10-26Sell497$32.1323.59view
LINDOP CHRISTOPHER JCFO & EVP Business Development 2015-10-26Sell436$32.1323.59view
Davies Kent JCOO 2015-10-23Sell278$31.7525.07view
Selman ByronPresident, Global Markets 2015-10-23Sell191$31.7525.07view

Quarterly/Annual Reports about HAE:

News about HAE:

Articles On GuruFocus.com
Weekly CEO Buys Highlights Aug 15 2016 
DENTSPLY´s Growth Opportunities Dec 16 2014 
Meridian Contrarian Fund Second Quarter Commentary Sep 08 2014 
Guru Held Stocks Near Historical Low P/B Jul 22 2014 
The Olstein All Cap Value Fund’s 2014 First Quarter Letter to Shareholders Jul 22 2014 
This Blood Management Company Can Be A Safe Investment Jul 13 2014 
Meridian Funds Comments on Haemonetics Aug 28 2013 
Meridian Funds' Second Quarter 2013 Commentary Aug 28 2013 
Weeky CFO Sells Highlight: ADBE, HAE, WAGE, OVTI, ICPT Jun 24 2013 
Allscripts-Misys Reports 5 Insider Buys the Day Before Barclays Conference Mar 13 2013 

More From Other Websites
Haemonetics (HAE) Hits a 52-Week High on Solid Prospects Nov 28 2016
Haemonetics: Medical Center of Plano Picks BloodTrack Nov 22 2016
The Medical Center of Plano Texas Selects Haemonetics® BloodTrack® Technology Nov 18 2016
The Medical Center of Plano Texas Selects Haemonetics® BloodTrack® Technology Nov 18 2016
HAEMONETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements... Nov 17 2016
HAEMONETICS CORP Financials Nov 17 2016
HAEMONETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers Nov 14 2016
Haemonetics Corp. :HAE-US: Earnings Analysis: Q2, 2017 By the Numbers : November 11, 2016 Nov 11 2016
ETF’s with exposure to Haemonetics Corp. : November 9, 2016 Nov 09 2016
Haemonetics upgraded by Barrington Research Nov 08 2016
Haemonetics (HAE) Q2 Earnings & Revenues Beat Estimates Nov 08 2016
Haemonetics Corp. breached its 50 day moving average in a Bullish Manner : HAE-US : November 8, 2016 Nov 08 2016
Edited Transcript of HAE earnings conference call or presentation 7-Nov-16 1:00pm GMT Nov 07 2016
Haemonetics Corp Earnings Call scheduled for 8:00 am ET today Nov 07 2016
Q2 2017 Haemonetics Corp Earnings Release - 06:00 am ET Nov 07 2016
HAEMONETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 07 2016
Haemonetics tops Street 2Q forecasts Nov 07 2016
Haemonetics tops Street 2Q forecasts Nov 07 2016
Haemonetics 2nd Quarter Fiscal 2017 Earnings Release Available on Investor Relations Website Nov 07 2016
Haemonetics 2nd Quarter Fiscal 2017 Earnings Release Available on Investor Relations Website Nov 07 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)